Sevelamer Carbonate Tablet, Film Coated
Product Images NDC 24979-186

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Sevelamer Carbonate (NDC 24979-186). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Twi Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Sevelamer Carbonate Chemical Structure (7397sevelamerimage 01)

Sevelamer Carbonate Chemical Structure (7397sevelamerimage 01)
This text is describing the number of primary amine groups and crosslinking groups present in a polymer network. Specifically, it states that there are 9 total primary amine groups and 1 crosslinking group. The mention of a "large number" may indicate that the polymer network is extensive, or that the polymer has a high molecular weight.*
FDA Label Image

Figure 2 (7397sevelamerimage 02)

FDA Label Image

Graph (7397sevelamerimage 03)

FDA Label Image

Twi (B5862d67 Figure 04)

FDA Label Image

Image Description (Label 800 mg)

Image Description (Label 800 mg)
This is a medication called Sevelamer Carbonate tablets which come in a film-coated form. Each tablet contains 300mg of Sevelamer Gutonal. The recommended dosage can be found on the package. It should be stored between 20-25°C and protected from moisture. The manufacturer is listed as Wi Pharmaceutias in the USA and Taopan Gy in Taiwan. The medication is available in a bottle with 270 tablets and can only be obtained with a prescription.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.